Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Insulin-specific T Cell Epitope (B chain 9–23) (InsB(9–23))
- Target
- InsB(9–23)
- Molecular classification
- Peptide, Autoantigen, T cell epitope
01
Overview
The insulin B chain residues 9 through 23 form a critical autoantigenic peptide recognized by pathogenic CD4+ T cells. This region's presentation by MHC class II molecules initiates autoimmune destruction characteristic of type 1 diabetes. Hybrid peptides containing portions of this sequence fused with other proteins may enhance its antigenicity. It is not a direct drug target, but rather an epitope for immunotherapy.
- Other names
- Insulin B:9-23InsB9-23
02
Mechanism of action
Not applicable (as a target). Therapeutic strategies aim to modulate immune responses to this epitope via altered peptide ligands or tolerogenic administration.
03
Biological functions
T cell activationAntigen presentationAutoimmune response
04
Disease associations
Type 1 Diabetes Mellitus
05
Safety considerations
Potential for immune activation or suppression depending on therapeutic approachRisk of exacerbating or preventing autoimmunity
06
Biomarkers
T cell reactivity to InsB(9-23)Levels of InsB(9-23)-specific autoantibodies
Beyond the preview
Go deeper on Insulin-specific T Cell Epitope (B chain 9–23) (InsB(9–23)).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Insulin-specific T Cell Epitope (B chain 9–23) (InsB(9–23)).